Letter to "May myo-inositol and D-chiro-inositol (40:1) treatment be a good option on normal-weighted polycystic ovary syndrome patients without insulin resistance?"

J Obstet Gynaecol Res. 2021 Feb;47(2):860. doi: 10.1111/jog.14590. Epub 2020 Dec 2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Body Weight
  • Female
  • Humans
  • Inositol
  • Insulin Resistance*
  • Polycystic Ovary Syndrome* / drug therapy

Substances

  • Inositol